GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » Piotroski F-Score

Solventum (FRA:KB7) Piotroski F-Score : 4 (As of Apr. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Solventum has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Solventum's Piotroski F-Score or its related term are showing as below:

FRA:KB7' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 4   Max: 4
Current: 4

During the past 5 years, the highest Piotroski F-Score of Solventum was 4. The lowest was 4. And the median was 4.


Solventum Piotroski F-Score Historical Data

The historical data trend for Solventum's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Piotroski F-Score Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
N/A N/A N/A N/A 4.00

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A 4.00

Competitive Comparison of Solventum's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, Solventum's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solventum's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Solventum's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 218.04 + 82.681 + 109.922 + 29.605 = €440 Mil.
Cash Flow from Operations was 406.64 + 329.795 + 152.269 + 209.145 = €1,098 Mil.
Revenue was 1854.72 + 1933.249 + 1875.882 + 1981.625 = €7,645 Mil.
Gross Profit was 1078.24 + 1056.273 + 1049.665 + 1068.645 = €4,253 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(12785.731 + 13534.12 + 13542.962 + 13285.245 + 13806.435) / 5 = €13390.8986 Mil.
Total Assets at the begining of this year (Dec23) was €12,786 Mil.
Long-Term Debt & Capital Lease Obligation was €7,459 Mil.
Total Current Assets was €3,103 Mil.
Total Current Liabilities was €2,581 Mil.
Net Income was 273.662 + 296.283 + 431.02 + 249.424 = €1,250 Mil.

Revenue was 1878.274 + 1916.148 + 1943.338 + 1867.012 = €7,605 Mil.
Gross Profit was 1061.958 + 1097.447 + 1132.833 + 1061.886 = €4,354 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(12832.736 + 0 + 13209.053 + 12999.001 + 12785.731) / 5 = €12956.63025 Mil.
Total Assets at the begining of last year (Dec22) was €12,833 Mil.
Long-Term Debt & Capital Lease Obligation was €7,614 Mil.
Total Current Assets was €2,310 Mil.
Total Current Liabilities was €1,585 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Solventum's current Net Income (TTM) was 440. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Solventum's current Cash Flow from Operations (TTM) was 1,098. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=440.248/12785.731
=0.03443276

ROA (Last Year)=Net Income/Total Assets (Dec22)
=1250.389/12832.736
=0.09743744

Solventum's return on assets of this year was 0.03443276. Solventum's return on assets of last year was 0.09743744. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Solventum's current Net Income (TTM) was 440. Solventum's current Cash Flow from Operations (TTM) was 1,098. ==> 1,098 > 440 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=7458.55/13390.8986
=0.55698652

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=7613.851/12956.63025
=0.5876413

Solventum's gearing of this year was 0.55698652. Solventum's gearing of last year was 0.5876413. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=3102.795/2581.365
=1.20199778

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=2309.923/1584.576
=1.45775463

Solventum's current ratio of this year was 1.20199778. Solventum's current ratio of last year was 1.45775463. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Solventum's number of shares in issue this year was 174.6. Solventum's number of shares in issue last year was 172.709. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4252.823/7645.476
=0.55625353

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4354.124/7604.772
=0.57255155

Solventum's gross margin of this year was 0.55625353. Solventum's gross margin of last year was 0.57255155. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=7645.476/12785.731
=0.59796941

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=7604.772/12832.736
=0.59260722

Solventum's asset turnover of this year was 0.59796941. Solventum's asset turnover of last year was 0.59260722. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Solventum has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Solventum  (FRA:KB7) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Solventum Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Solventum's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Solventum Headlines

No Headlines